BRIEF

on Biophytis (EPA:ALBPS)

Biophytis to Participate in BIOMED FORUM Investor Conference

Stock price chart of Biophytis (EPA:ALBPS) showing fluctuations.

Biophytis SA, a biotechnology company at the clinical stage, will participate in the Biomed Forum in Paris on February 4, 2025. This event is organized by All Invest Securities and serves as a key meeting for the healthcare sector. At the forum, Biophytis will engage with French and European investors. The company plans to share updates on its recent developments and present its 2025 outlook.

The Biomed Forum annually brings together biotech and medtech firms with institutional investors, facilitating connections and dialogue. Biophytis specializes in developing treatments for age-related conditions. This participation aligns with its strategic goals of fostering investor relations and expanding market presence.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Biophytis news